伺服电缸
Search documents
宁波华翔子公司携手大寰机器人,拟在通用人形机器人灵巧手领域开展合作
Zheng Quan Shi Bao Wang· 2025-12-22 10:32
Core Viewpoint - Ningbo Huaxiang's subsidiary, Huaxiang Qiyuan, has signed a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance the development and manufacturing of general-purpose humanoid robot dexterous hands, aiming to drive innovation in the robot supply chain and product development [1][2]. Group 1: Strategic Cooperation - The cooperation focuses on the development and mass production of a specific six-degree-of-freedom dexterous hand product, with Dahuan Robot responsible for product design and development verification, while Huaxiang Qiyuan handles solution confirmation, mass assembly, and sales to clients [1]. - This agreement is seen as a strategic extension of Huaxiang Qiyuan's main business, which will not alter the company's core operations or independence [2]. Group 2: Company Background and Future Outlook - Ningbo Huaxiang primarily engages in the design, development, production, and sales of automotive parts, serving major automotive manufacturers such as Volkswagen, Mercedes-Benz, BMW, and various domestic electric vehicle makers [2]. - The strategic partnership is expected to deepen the construction of the robot industry chain and accelerate the realization of Huaxiang Qiyuan's vision to become a "hardware manufacturing solution service provider" [2]. - The company plans to leverage its advanced manufacturing experience in the automotive parts sector to participate in the embodied intelligent robot industry chain, which may enhance operational efficiency and optimize cost structures in the long term [3].
专访大寰机器人:突破“最后一厘米”,打造机器“灵巧之手”
Nan Fang Du Shi Bao· 2025-06-04 08:56
Group 1 - The core focus of the Guangdong provincial government is to promote the development of the artificial intelligence and robotics industries, aiming to create a high-tech and high-growth industrial pillar [2][3] - The establishment of the Guangdong Artificial Intelligence and Robotics Industry Alliance is a strategic move to gather resources and enhance the industry's capabilities [2] - The initiative aligns with the national strategy for developing artificial intelligence and robotics, emphasizing high-quality development and innovation [2] Group 2 - Dahuang Robotics is a national high-tech enterprise specializing in industrial intelligent manufacturing, providing core components for precision motion and force control [5][6] - The company was founded by a team with a strong technical background, led by a prominent academic in robotics, aiming to address the limitations of existing robotic end-effectors [6] - Dahuang Robotics has developed a product matrix that includes dexterous hands, electric grippers, and other components, filling gaps in domestic precision manufacturing [8] Group 3 - The company's core technologies include precision control and feedback, high-precision force control, integrated technology, and intelligent technology, achieving superior performance compared to industry standards [10] - Dahuang Robotics has successfully implemented a closed-loop force control algorithm that significantly improved product yield rates for clients [11] - The company emphasizes its ability to provide customized solutions and rapid local support, which has helped it maintain a competitive edge in the market [11] Group 4 - The industry is witnessing a shift from pneumatic to electric technologies, with electric actuators expected to replace pneumatic grippers due to their advantages in precision and energy efficiency [12] - Key trends in the robotics industry include modularization, intelligent perception, and the emergence of collaborative robots, which are expected to drive demand for advanced components [12][13] - Dahuang Robotics aims to lead in the global market for dexterous actuators, focusing on the integration of AI and physical systems to enhance precision and intelligence [13]
鼎智科技(873593):业绩恢复趋势明显 全维度布局人形机器人运动控制系统核心部件
Xin Lang Cai Jing· 2025-05-25 08:31
Core Insights - The company's performance shows a clear recovery trend driven by strong growth in the industrial control segment and a rebound in the medical business, with the industrial control segment becoming a new growth engine [1] - The company achieved revenue of 0.59 billion yuan in Q1 2025, a year-on-year increase of 35.76%, and a net profit attributable to shareholders of 0.13 billion yuan, up 135.75% year-on-year, primarily due to the performance of linear actuators and DC motors [1] - The linear actuator revenue in 2024 reached 1.35 billion yuan, a year-on-year increase of 4.24%, while the DC motor segment grew by 32.78% year-on-year [1] - The decline in performance in 2024 was mainly due to a significant drop in the voice coil motor business, which fell by 91.31% year-on-year, impacted by market demand and inventory consumption [1] - The IVD business is expected to recover as customer inventory depletion is nearly complete, with growth anticipated in IVD orders and expansion into industrial automation, semiconductor, and 3C electronics sectors [1] Strategic Direction - The company is strategically focused on humanoid robots, developing a comprehensive range of core components for motion control systems, including dexterous hands, rotary joints, and linear joints [2] - The company offers various products such as hollow cup motors, precision gearboxes, and ball screws for these applications, with a research and development expense ratio increasing to 10.91% in 2024 [2] - Collaborations with multiple domestic and international humanoid robot industry clients are underway, indicating a strong market position [2] - The global humanoid robot market is projected to reach 12,400 units and 6.339 billion yuan in 2025, with an expected compound annual growth rate of 58.8% until 2030 [2] Capacity Expansion and Global Strategy - New production capacity is being gradually released, with the company's projects for an annual production of 1.8 million micro motors and a new R&D center officially launched in June 2024 [3] - A manufacturing base for screw motors in Thailand is set to begin production in Q3 2025, enhancing the company's global supply chain and competitiveness [3] - The company's performance is expected to enter a growth trend due to the recovery of the medical segment, continued expansion in industrial control, and the release of new production capacity [3] - Revenue forecasts for 2025-2027 are projected at 2.58 billion yuan, 3.05 billion yuan, and 3.72 billion yuan, with year-on-year growth rates of 15.12%, 18.34%, and 21.96% respectively [3]